“Quite frankly I don’t know who holds the PBMs accountable for any public responsibility. I think that’s the challenge. Taxpayers are the largest payors and consumers of pharmaceutical products and yet the PBMs that play a critical role in this are really not accountable to us. To me that’s the major challenge.”